Noxxon Pharma

NuVox Pharma

This clinical-stage biotechnology company develops oxygen therapeutics to treat hypoxia in patients at comprehensive centres for oncology, stroke and respiratory care.

Bicara Therapeutics

This biotechnology company develops dual-action biologics to treat patients with solid tumours by targeting the tumour microenvironment.

Carrick Therapeutics

This biopharmaceutical company develops precision oncology therapies for patients with aggressive cancers, focusing on small molecules and inhibitors for solid tumours.

Ariceum Therapeutics

This clinical-stage biotechnology company develops targeted radiopharmaceutical therapies for the diagnosis and treatment of aggressive, hard-to-treat cancers.

Targovax AS (Oncos)

This biotechnology company develops circular RNA therapeutics and oncolytic virus-based immunotherapies for patients with solid tumours and other difficult-to-treat diseases.

Nuvectis Pharma

This biopharmaceutical company develops precision medicines and targeted small molecule therapeutics for patients with advanced cancers and other serious conditions.

Arch Oncology

This biotechnology firm develops antibody therapies to treat patients with solid tumours and hematologic malignancies.

Micromet

This biotechnology firm develops antibody therapies for cancer and autoimmune disease treatment for patients and pharmaceutical partners.